Severe Graves' ophthalmopathy after retrobulbar anesthesia for cataract extraction in a patient with mild stable thyroid eye disease

Thyroid

Volumn 13, Issue 8, 2003, Pages 823-826

  Wai, Daniel Chun Hang ^a   Ho, Su Chin ^a   Seah, Lay Leng ^b   Fong, Kee Siew ^b   Khoo, Daphne Hsu Chin ^a  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

^b SINGAPORE NATIONAL EYE CENTRE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

CARBIMAZOLE; PREDNISOLONE; RADIOACTIVE IODINE; STEROID; THYROID STIMULATING IMMUNOGLOBULIN;

AGED; ARTICLE; CASE REPORT; CATARACT EXTRACTION; DECOMPRESSION SURGERY; DIPLOPIA; ENDOCRINE OPHTHALMOPATHY; EXOPHTHALMOS; EXTRAOCULAR MUSCLE; GRAVES DISEASE; HUMAN; IMMUNE RESPONSE; INFLAMMATION; INJURY; KERATITIS; MALE; MUSCLE FUNCTION; MYXEDEMA; OPHTHALMOPLEGIA; PRIORITY JOURNAL; RETROBULBAR ANESTHESIA; VISUAL ACUITY; VISUAL DISORDER;

EID: 0042830716     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/105072503768499725     Document Type: Article

References (32)

1. Marino M, Lisi S, Pinchera A, Mazzi B, Latrofa F, Sellari-Franceschini S, McCluskey RT, Chiovato L 2001 Identification of thyroglobulin in orbital tissues of patients with thyroid-associated ophthalmopathy. Thyroid 11:177-185.
2. Many M, Costagliola S, Detrait M, Denef F, Vassart G, Ludgate M 1999 Development of an animal model of autoimmune thyroid eye disease. J Immunol 162:4966-4974.
3. Ludgate M, Crisp M, Lane C, Costagliola S, Vassart G, Weetman A, Dauneric C, Many MC 1999 The thyrotropin receptor in thyroid eye disease [review]. Thyroid 8:411-413.
4. Volpe R, Sawin C 2000 Graves' disease: A historical perspective. In: Rapoport B, McLachlan SM (eds) Graves' Disease: Pathogenesis and Treatment. Boston, Kluwer Academic Publishers, pp. 1-6.
5. Busuttil BE, Frauman AG 2001 Extrathyroidal manifestations of Graves' disease: The thyrotropin receptor is expressed in extraocular, but not cardiac, muscle tissues. J Clin Endocrinol Metab 86:2315-2319.
6. Heufelder AE, Dutton CM, Sarkar G, Donovan KA, Bahn RS 1993 Detection of TSH receptor RNA in cultured fibroblasts from patients with Graves' ophthalmopathy and pretibial dermopathy. Thyroid 3:297-300.
7. Feliciello A, Porcellini A, Ciullo I, Bonavolonta G, Avvedimento EV, Fenzi G 1993 Expression of thyrotropin-receptor mRNA in healthy and Graves' disease retro-orbital tissue. Lancet 342:337-338.
8. Daumerie C, Ludgate M, Costagliola S, Many MC 2002 Evidence for thyrotropin receptor immunoreactivity in pretibial connective tissue from patients with thyroid-associated dermopathy. Eur J Endocrinol 146:35-38.
9. Rapoport B, Alsabeh R, Aftergood D, McLachlan SM 2000 Elephantiasic pretibial myxedema: Insight into and a hypothesis regarding the pathogenesis of the extrathyroidal manifestations of Graves' disease. Thyroid 10:685-692.
10. Stadlmayr W, Spitzweg C, Bichlmair AM, Heufelder AE 1997 TSH receptor transcripts and TSH receptor-like immunoreactivity in orbital and pretibial fibroblasts of patients with Graves' ophthalmopathy and pretibial myxedema. Thyroid 7:3-12.
11. Wu SL, Chang TC, Chang TJ, Kuo YF, Hsiao YL, Chang CC 1996 Cloning and sequencing of complete thyrotropin receptor transcripts in pretibial fibroblast culture cells. J Endocrinol Invest 19:365-370.
12. Dutton CM, Joba W, Spitzweg C, Heufelder AE, Bahn RS 1997 Thyrotropin receptor expression in adrenal, kidney, and thymus. Thyroid 7:879-884.
13. Drvota V, Janson A, Norman C, Sylven C, Haggblad J, Bronnegard M, Marcus C 1995 Evidence for the presence of functional thyrotropin receptor in cardiac muscle. Biochem Biophys Res Commun 211:426-431.
14. Bell A, Gagnon A, Grunder L, Parikh SJ, Smith TJ, Sorisky A 2000 Functional TSH receptor in human abdominal preadipocytes and orbital fibroblasts. Am J Physiol Cell Physiol 279:C335-C340.
15. Prummel MF, Brokken LJ, Meduri G, Misrahi M, Bakker O, Wiesinga WM 2000 Expression of the thyroid-stimulating hormone receptor in the folliculo-stellate cells of the human anterior pituitary. J Clin Endocrinol Metab 85:4347-4353.
16. Smith TJ, Koumas L, Gagnon A, Bell A, Sempowski GD, Phipps RP, Sorisky A 2002 Oribital fibroblast heterogeneity may determine the clinical presentation of thyroid-associated ophthalmopathy. J Clin Endocrinol Metab 87:385-392.
17. Smith TJ 2002 Oribtal fibroblasts exhibit a novel pattern of responses to proinflammatory cytokines: Potential basis for the pathogenesis of thyroid-associated ophthalmopathy. Thyroid 12:197-203.
18. Johnson DA 2001 Persistent vertical binocular diplopia after cataract surgery. Am J Ophthalmol 132:831-835.
19. Cadera W 1998 Diplopia after peribulbar anesthesia for cataract surgery. J Pediatr Ophthalmol Strabismus 35:240-241.
20. Hamed LM, Lingua RW 1990 Thyroid eye disease presenting after cataract surgery. J Pediatr Ophthalmol Strabismus 27:10-15.
21. Rainin EA, Carlson BM 1985 Postoperative diplopia and ptosis. A clinical hypothesis based on the myotoxicity of local anesthetics. Arch Ophthalmol 103:1337-1339.
22. Carlson BM, Rainin EA 1985 Rat extraocular muscle regeneration. Repair of local anesthetic-induced damage. Arch Ophthalmol 103:1373-1377.
23. Bartalena L, Marcocci C, Bogazzi F, Manetti L, Tanda ML, Dell'Unto E, Bruno-Bossio G, Nardi M, Bartolomei MP, Lepri A, Rossi G, Martino E, Pinchera A 1998 Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy. N Engl J Med 338:73-78.
24. Burmeister LA, Beatty RL, Wall JR 1999 Malignant ophthalmopathy presenting one week after radioiodine treatment of hyperthyroidism. Thyroid 9:189-192.
25. Gorman CA, Garrity JA, Fatourechi V, Bahn RS, Petersen IA, Stafford SL, Earle JD, Forbes GS, Kline RW, Bergstralh EJ, Offord KP, Rademacher DM, Stanley NM, Bartley GB 2001 A prospective, randomized, double-blind, placebo-controlled study of orbital radiotherapy for Graves' ophthalmopathy. Ophthalmology 108:1523-1534.
26. Mourits MP, van Kempen-Harteveld ML, Garcia MB, Koppeschaar HP, Tick L, Terwee CB 2000 Radiotherapy for Graves' orbitopathy: Randomised placebo-controlled study. Lancet 355:1505-1509.
27. Bartalena L, Pinchera A, Marcocci C 2000 Management of Graves' ophthalmopathy: Reality and perspectives. Endocr Rev 21:168-199.
28. Muhlberg T, Joba W, Spitzweg C, Schworm HD, Heberling HJ, Heufelder AE 2000 Interleukin-1 receptor antagonist ribonucleic acid and protein expression by cultured Graves' and normal orbital fibroblasts is differentially modulated by dexamethasone and irradiation. J Clin Endocrinol Metab 85:734-742.
29. Khoo DH, Ho SC, Seah LL, Fong KS, Tai E, Chee S, Eng PH, Aw SE, Fok AC 1999 The combination of absent thyroid peroxidase antibodies and high thyroid stimulating immunoglobulin levels in Graves' disease identifies a group at markedly increased risk of ophthalmopathy. Thyroid 9: 1175-1180.
30. Khoo DH, Eng PH, Ho SC, Tai ES, Morgenthaler NG, Seah LL, Fong KS, Chee SP, Choo CT, Aw SE 2000 Graves' ophthalmopathy in the absence of elevated free thyroxine and triiodothyronine levels: Prevalence, natural history and TSH-receptor antibody levels. Thyroid 10:1093-1100.
31. Gupta MK, McBride N, Secic M, Sheeler L, Kohse L, Licata A. TSH receptor antibodies in Graves' ophthalmopathy: high association and predictive role of thyroid stimulating but not TSH binding inhibitory antibodies. Endocr J 1994;2: 305-310.
32. Gerding MN, van der Meer JW, Broenink M, Bakker O, Wiersinga WM, Prummel WF 2000 Association of thyrotrophin receptor antibodies with the clinical features of Graves' ophthalmopathy. Clin Endocrinol 52:267-271.